Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
about
Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagenJoint-specific and systemic autoreactivity in the development of inflammatory arthritis.Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.The immunologic homunculus in rheumatoid arthritis.Vaccination strategies for mucosal immune responsesFood for thought: can immunological tolerance be induced to treat asthma?New therapies in development for autoimmune diseases: their rationale for combination treatment.A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis.Grape-seed proanthocyanidin extract as suppressors of bone destruction in inflammatory autoimmune arthritis.Effect of type II collagen treatment on the antioxidant status in immune tissues of adjuvant induced arthritic rats.Nutritional Approach for Relief of Joint Discomfort: A 12-week, Open-case Series and Illustrative Case Report.Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?Oral Administration of Shark Type II Collagen Suppresses Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Rats.Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosisSafety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial.Treating arthritis by immunomodulation: is there a role for regulatory T cells?Induction of immune tolerance in the treatment of rheumatoid arthritis.Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.Safety and toxicological evaluation of a novel, water-soluble undenatured type II collagen.Oral and nasal administration of chicken type II collagen suppresses adjuvant arthritis in rats with intestinal lesions induced by meloxicamUrsolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation.Effects of Native Type II Collagen Treatment on Knee Osteoarthritis: A Randomized Controlled Trial.Control of rheumatoid arthritis by oral tolerance.Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis.The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis.Safety and toxicological evaluation of undenatured type II collagen.Bacterial extract (OM-89) specific and non specific immunomodulation in rheumatoid arthritis patients.
P2860
Q24800770-8CD638BF-8B2D-4E70-A36E-0E4CFA2C1D2BQ24806616-39F4CF32-B475-46A3-9E8F-DB2400E91C9AQ33546205-1EFBDCD8-DE83-4349-86CB-DD8EE1CCF1AFQ33713407-D428DCCB-0623-4365-A5CA-6528F4D5176DQ33806414-E1129620-A415-4969-907D-3BBBE0474EA6Q33975703-D4F73884-1E35-4C6A-A7C9-DE0B6365AC70Q34249844-1D1D9906-08B9-4FFA-AF0D-BEEF00C1F3ECQ34309745-404879AE-2E9D-42A3-B599-CC0CE4EB94CFQ34413341-D80B8A1C-7CAD-4FC4-94AC-A464D985ED1DQ34516523-AB841C8B-F5BA-49AD-A96D-ED5ED8CAA7E1Q36264913-EDC47B97-DA72-4064-9AF7-F9C5C52A3AEEQ36462631-F4CC91BB-5B7C-4B08-BDAB-7EA3193EF154Q37120570-9719E9C0-4763-4D36-A8A0-0F9887E9F96FQ37148727-79EE21F4-8804-4FC7-87B9-BFB82DE7BAB8Q37364480-AAA1F0ED-CC19-4A2D-89F9-97F37E004FD1Q37393275-175847DF-57C1-46C7-B779-F6E556AEF7B9Q37750140-7CC3439D-A33F-476A-8E8E-75EA6829230EQ37862081-C3D959EE-F045-4B02-8F48-EC1D6AFEF042Q38078552-745F820E-20D2-4711-A52F-0A620E8254F8Q38274532-D41DCFA1-63EF-42D8-A85F-BDED7A54247EQ39182757-707F063A-86C2-44EC-A109-43B041F85952Q41981567-37C20B13-B5A2-4781-8229-99F27F5F6636Q42005675-514F9171-C20E-4211-B1F4-999DDC851BE3Q42113278-AEC1A773-D384-4944-B47F-5CE64C3D8631Q43760454-FCBB111A-65C8-407D-981F-16C5F44406B4Q44461538-E1773049-F65A-4617-BCB9-A00CD8D1BD37Q46201135-E6606F73-9ABD-4263-9201-BD19726FCCA3Q47641325-D10FCA20-B3CD-4A3F-9F0F-9919763B0825Q48300377-BB222274-FD1C-45EE-ADD9-3D92741A4EFAQ54458259-A62A19D7-3222-4751-8A7A-CA5F3E3426E8
P2860
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@ast
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@en
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@nl
type
label
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@ast
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@en
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@nl
prefLabel
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@ast
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@en
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@nl
P2093
P1476
Treatment of rheumatoid arthri ...... ind, placebo-controlled trial.
@en
P2093
Barnett ML
Chasan-Taber S
Fletcher MJ
St Clair EW
P304
P356
10.1002/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R
P577
1998-02-01T00:00:00Z